首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Bayesian Risk Assessment in Genetic Testing for Autosomal Dominant Disorders with Age-Dependent Penetrance
Authors:Shuji Ogino  Robert B Wilson  Bert Gold  Pamela Flodman
Institution:(1) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;(2) Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;(3) Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, PA, USA;(4) Human Genetics Section, Laboratory of Genomic Diversity, National Cancer Institute at Frederick, Frederick, MD, USA;(5) Department of Pediatrics, University of California Irvine, Irvine, CA, USA;(6) Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02115, USA
Abstract:Risk assessment is an essential component of genetic counseling and testing, and the accuracy of risk assessment is critical for decision making by consultands. However, it has been shown that genetic risk calculations may have high error rates in practice. Risk calculations for autosomal dominant disorders are frequently complicated by age-dependent penetrance and sensitivities of less than 100% in genetic testing. We provide methods of risk calculation for prototypical pedigrees of a family at risk for an autosomal dominant disorder with age-dependent penetrance. Our risk calculations include scenarios in which the sensitivity of genetic testing is less than 100%, and in which the sensitivity of genetic testing varies for different family members at risk. Our Bayesian methods permit autosomal dominant disease probabilities to be calculated accurately, taking into account all relevant information. Our methods are particularly useful for hereditary cancer syndromes, in which genetic testing can seldom achieve 100% sensitivity. Our methods can be applied to many different scenarios, including those where the sensitivity of genetic testing varies for different family members at risk. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Keywords:bayes  bayesian  genetic risk  risk assessment  genetic counseling  autosomal dominant  hereditary cancer  penetrance  sensitivity
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号